Screening for Cardiovascular Disease Risk With Electrocardiography: US Preventive Services Task Force Recommendation...

Area of Science:

• Cardiovascular Medicine
• Preventive Cardiology
• Diagnostic Testing

Background:

• Cardiovascular disease (CVD) is a leading cause of death in the US, with risk assessment tools like Framingham Risk Score guiding preventive strategies.
• Current guidelines for CVD prevention rely on risk stratification to inform treatment decisions for asymptomatic adults.

Purpose of the Study:

• To update the US Preventive Services Task Force (USPSTF) recommendation on screening for coronary heart disease using electrocardiography (ECG).
• To evaluate the effectiveness of ECG screening compared to traditional risk assessment in asymptomatic adults.

Main Methods:

• Systematic review of evidence on resting or exercise ECG screening in asymptomatic adults.
• Comparison of health outcomes between ECG screening and conventional CVD risk assessment alone.

Main Results:

• For low-risk asymptomatic adults, ECG screening offers minimal benefit beyond existing risk assessment and carries potential harms from subsequent invasive procedures.
• For intermediate and high-risk asymptomatic adults, evidence is insufficient to determine if ECG screening improves risk management or reduces CVD events.

Conclusions:

• The USPSTF recommends against ECG screening for low-risk asymptomatic adults due to unlikely benefits and potential harms.
• The USPSTF found insufficient evidence to assess the benefits and harms of ECG screening for intermediate or high-risk asymptomatic adults.